Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.

Li J, Dai L, Lei N, Xing M, Li P, Luo C, Casiano CA, Zhang JY. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Oncotarget. 2016 Jul 12; 7(28):43546-43556.

View in: PubMed

subject areas

Aged
Antigens, Neoplasm
Area Under Curve
Autoantibodies
Autoantigens
Blotting, Western
Enzyme-Linked Immunosorbent Assay
Humans
Immunohistochemistry
Male
Microscopy, Fluorescence
Middle Aged
Neoplasm Staging
Prostate
Prostate-Specific Antigen
Prostatic Hyperplasia
Prostatic Neoplasms
ral GTP-Binding Proteins
Recombinant Proteins
Retrospective Studies
ROC Curve
Tissue Array Analysis

authors with profiles

Jianying Zhang

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support